Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Innovation & Technology

The Case for PrEP


1. Early data in animal studies strongly suggest the strategy is effective.

2. Glaxo's Combivir is already prescribed to prevent infections in men who take it after unprotected sex with an HIV-positive partner.

3. Some 74% of participants in a 2009 survey of gay men said they would use PrEP if it were available.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus